OCTA in Patients With Primary Open-angle Glaucoma

Launched by ASSIUT UNIVERSITY · Jan 10, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how blood vessels in the retina, the light-sensitive layer at the back of the eye, change in patients with primary open-angle glaucoma. The researchers will use a special imaging technique called Optical Coherence Tomography Angiography (OCTA) to study these changes. The goal is to learn more about the condition and how it affects the eyes.

To participate in this trial, individuals should be between the ages of 65 and 74 and have a clinical diagnosis of primary open-angle glaucoma. Unfortunately, those with certain eye problems, like severe vision loss or other eye diseases, will not be eligible. Participants can expect to undergo OCTA imaging, which is a non-invasive procedure that takes pictures of the blood vessels in the eye. This study is currently not yet recruiting participants, but it will help doctors better understand glaucoma and improve future treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - clinical diagnosis of Primary open angle glaucoma.
• Exclusion Criteria:
• • media opacity
• • poor fixation due to advanced disease
• • associated vascular retinopathy
• • chronic uveitis
• • optic nerve disease due to other etiologies